Pacira Biosciences Inc
NASDAQ:PCRX
Wall Street
Price Targets
PCRX Price Targets Summary
Pacira Biosciences Inc
According to Wall Street analysts, the average 1-year price target for
PCRX
is 30.31 USD
with a low forecast of 23.23 USD and a high forecast of 39.9 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is PCRX's stock price target?
Price Target
30.31
USD
According to Wall Street analysts, the average 1-year price target for
PCRX
is 30.31 USD
with a low forecast of 23.23 USD and a high forecast of 39.9 USD.
What is Pacira Biosciences Inc's Revenue forecast?
Projected CAGR
8%
For the last 14 years the
compound annual growth rate for
Pacira Biosciences Inc's revenue is
32%.
The projected
CAGR
for the next 3 years is
8%.
What is Pacira Biosciences Inc's Operating Income forecast?
Projected CAGR
87%
The
compound annual growth rate
of Pacira Biosciences Inc's operating income for the next 3 years is
87%.
What is Pacira Biosciences Inc's Net Income forecast?
Projected CAGR
190%
The
compound annual growth rate
of Pacira Biosciences Inc's net income for the next 3 years is
190%.
